PEPTIDE

KPV

KPV (Lysine-Proline-Valine) is a small tripeptide derived from the C-terminal of α-melanocyte-stimulating hormone (α-MSH). It delivers potent, targeted inflammation-pathway research observations independent of melanocortin receptor binding, modulating intracellular inflammatory pathways (e.g., NF-κB) to support gut mucosal repair, skin healing, and immune regulation without the melanin-stimulating side effects of full-length α-MSH.

KPV (Lysine-Proline-Valine) is a synthetic tripeptide corresponding to the C-terminal bioactive fragment of α-melanocyte-stimulating hormone (α-MSH), optimized for targeted anti-inflammatory research:

Core Mechanism & Defining Properties

Delivers potent inflammation-pathway research observations via melanocortin receptor-independent modulation of intracellular inflammatory signaling pathways (including NF-κB and MAPK cascades)
Eliminates the melanin-stimulating (pigment-inducing) side effects of full-length α-MSH, retaining only the parent hormone’s anti-inflammatory and immune-regulating activity
Exhibits excellent cell and tissue penetration, enabling targeted action in gut mucosa, skin, and other inflamed tissues
Supports resolution of inflammation without broad immune suppression, preserving normal host defense function

Primary Research Applications

Inflammatory bowel disease and gut mucosal repair research
Dermatological inflammation and wound healing studies
Chronic inflammation and immune regulation models
Investigations of targeted anti-inflammatory therapy without melanogenic side effects

Manufactured to ≥99% purity, sterile-filtered, and lyophilized for long-term stability.

For laboratory research use only; not intended for human or veterinary administration.

Research use only: This material is supplied for laboratory research and documentation workflows only. It is not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.

Hytan procurement and documentation support

For KPV, Hytan Peptides can support research-use sourcing review with available batch COA, vial labeling, product identity notes, storage documentation and wholesale quantity discussion. Product-specific CAS, sequence, molecular weight or method details should be confirmed against the current batch document before procurement decisions.

COA review: request batch-specific purity and identity references where available.
Wholesale planning: confirm vial strength, quantity, lead time, packing and destination requirements.
Compliance: research-use wording should remain clear in quote, invoice and receiving records.

Manufacturing Capability

Controlled production for consistent research peptide supply

Hytan Peptides supports wholesale research peptide orders with organized production workflow, clean handling, standardized filling, labeling and batch-level documentation. From material preparation to final review, each step is managed to support consistent appearance, traceable COA records and dependable supply coordination.

This production overview helps laboratories, distributors and qualified research buyers understand how Hytan Peptides approaches quality-focused peptide manufacturing, packaging and order readiness.